RELIEF THERAPEUTICS HLDG AG financial statements, including revenue, expenses, profit, and loss
The total revenue of RLFTY for the last semiannual is 3.40 M USD, and it's 2.57% higher compared to the previous semiannual. The net income of H2 23 is -47.08 M USD.